Clinical and economical improvements after introducing rapid identification of bacteria and early antibiotic susceptibility testing in sepsis and bloodstream infections. Results of...

by Wilke, Michael, Heinlein, Wolfgang, Stiefenhofer, Luis, Bodmann, Klaus-Friedrich
Published 2020-12-01

Potential savings through single-dose intravenous Dalbavancin in long-term MRSA infection treatment – a health economic analysis using German DRG data

by Wilke, Michael, Worf, Kerstin, Preisendörfer, Birgit, Heinlein, Wolfgang, Kast, Tilman, Bodmann, Klaus-Friedrich
Published 2019-10-01